Life sciences organizations are under pressure to accelerate time to market while adhering to rigorous compliance standards. A recent report commissioned by DocuSign found that improving business agility and compliance are critical priorities for the majority of life sciences companies.
But what stands in the way of business agility? Onerous manual paper processes prone to error and not adopting new technology because of lack of confidence in its validation. For instance, life science organizations has numerous contracts, forms, and regulatory documentation that needs to be prepared, signed, acted on, and managed. Yet these agreements also need to be validated and compliant. Streamlining this system of agreement and having confidence during ongoing validations are instrumental to accelerating product development and engaging patients in order drive business growth.
Learn how industry leaders are using DocuSign to modernize their systems of agreement while implementing GxP validation processes. Hear best practices about how to simplify and scale your business processes while also reducing your regulatory risk.